Twist Bioscience Corp — Director's Dealing 2019

Oct 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2019-07-23

Reporting Person: CRAVES FRED B (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-23	Director Stock Option (right to buy)	$30.41	A	5590	Acquired	2029-07-22	Common Stock (5590)	Direct

Footnotes

F1: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date.